Sonoma Pharmaceuticals
SNOA
#10572
Rank
NZ$6.95 M
Marketcap
NZ$4.02
Share price
-5.35%
Change (1 day)
6.09%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -NZ$5.37 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$16.93 Million. In 2024 the company made an earning of -NZ$7.8 Million a decrease over its 2023 earnings that were of -NZ$7.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.37 Million-31.23%
2024 -NZ$7.8 Million0.54%
2023 -NZ$7.76 Million-31.5%
2022 -NZ$11.33 Million16.86%
2021 -NZ$9.7 Million194.32%
2020 -NZ$3.3 Million-58.76%
2019 -NZ$7.99 Million-65.66%
2018 -NZ$23.26 Million4.84%
2017 -NZ$22.18 Million-2.17%
2016 -NZ$22.67 Million32.12%
2015 -NZ$17.16 Million-307.74%
2014 NZ$8.25 M-197.5%
2013 -NZ$8.48 Million
2010 -NZ$13.24 Million-14.02%
2009 -NZ$15.4 Million-57.28%
2008 -NZ$36.04 Million-8.03%
2007 -NZ$39.18 Million3.85%
2006 -NZ$37.73 Million39.31%
2005 -NZ$27.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.73 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA